PNC Financial Services Group Inc. Sells 186 Shares of Amedisys, Inc. (NASDAQ:AMED)

PNC Financial Services Group Inc. cut its stake in Amedisys, Inc. (NASDAQ:AMED) by 2.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,486 shares of the health services provider’s stock after selling 186 shares during the period. PNC Financial Services Group Inc.’s holdings in Amedisys were worth $617,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Cetera Trust Company N.A bought a new position in shares of Amedisys during the 4th quarter worth about $215,000. CWM LLC lifted its holdings in shares of Amedisys by 40.4% during the 4th quarter. CWM LLC now owns 2,629 shares of the health services provider’s stock worth $250,000 after acquiring an additional 757 shares during the period. Contravisory Investment Management Inc. bought a new position in shares of Amedisys during the 4th quarter worth about $258,000. Mesirow Institutional Investment Management Inc. lifted its holdings in shares of Amedisys by 9.9% during the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider’s stock worth $270,000 after acquiring an additional 257 shares during the period. Finally, Federated Hermes Inc. lifted its holdings in shares of Amedisys by 32.9% during the 4th quarter. Federated Hermes Inc. now owns 3,518 shares of the health services provider’s stock worth $334,000 after acquiring an additional 871 shares during the period. 94.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th. StockNews.com upgraded shares of Amedisys from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Cantor Fitzgerald reiterated a “neutral” rating and set a $101.00 target price on shares of Amedisys in a research report on Thursday, April 25th. Finally, Royal Bank of Canada increased their target price on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, March 25th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Amedisys presently has a consensus rating of “Hold” and a consensus price target of $100.80.

Amedisys Trading Down 0.1 %

AMED opened at $92.00 on Thursday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $3.01 billion, a PE ratio of -143.75, a PEG ratio of 2.26 and a beta of 0.80. Amedisys, Inc. has a 1-year low of $89.55 and a 1-year high of $97.36. The firm has a 50-day moving average price of $93.01 and a two-hundred day moving average price of $93.47.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.01. The firm had revenue of $571.41 million during the quarter, compared to analysts’ expectations of $565.38 million. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.00 EPS. As a group, equities analysts anticipate that Amedisys, Inc. will post 4.57 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.